Get the Stockscreener App
0.6147
2.69%
-0.017
Lakewood Amedex Biotherapeutics Inc Stock (LABT) Forecast
The Lakewood Amedex Biotherapeutics Inc (LABT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $43.86, representing a +7,035% increase from the current price of $0.6147. The highest analyst price target is $51.02, and the lowest is $36.70.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LABT Price Target
Average 55.93
(+8,998% Upside)
Is Lakewood Amedex Biotherapeutics Inc (LABT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 22.24 | Buy |
| STOCH(9,6) | 5.1308 | Buy |
| STOCHRSI(14) | 1.2401 | Buy |
| MACD(12,26) | -0.3844 | Sell |
| ADX(14) | 31.01 | Sell |
| William %R | -98.14 | Buy |
| CCI(14) | -31.44 | Neutral |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7745
Sell
|
0.812
Sell
|
| MA20 |
1.1538
Sell
|
1.0959
Sell
|
| MA50 |
1.8021
Sell
|
2.3708
Sell
|
| MA100 |
2.9679
Sell
|
6.4003
Sell
|
| MA200 |
4.7818
Sell
|
0.00
Buy
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, LABT could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 11 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on LABT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 22.24 indicates that LABT is oversold. This indicates that LABT price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 5.1308 indicates that LABT is oversold. This indicates that LABT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 1.2401 indicates that LABT is oversold. This suggests that LABT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 31.01 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -31.44 indicates that LABT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term LABT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lakewood Amedex Biotherapeutics Inc financial reports and earnings history, Lakewood Amedex Biotherapeutics Inc (LABT) stock could reach $174.68 by 2030, $1,650.64 by 2040 and $1,897.97 by 2050. See the projected annual prices until 2050 of the Lakewood Amedex Biotherapeutics Inc stock below:
- Lakewood Amedex Biotherapeutics Inc (LABT) is expected to reach an average price of $656.82 in 2035, with a high prediction of $796.25 and a low estimate of $656.96. This indicates an $106.75K% rise from the last recorded price of $0.6147.
- Lakewood Amedex Biotherapeutics Inc (LABT) stock is projected to chart a bullish course in 2040, with an average price target of $1,544.46, representing an $251.15K% surge from its current level. The forecast ranges from a conservative $69.17 to a sky-high $1,650.64.
- Our analysts predict Lakewood Amedex Biotherapeutics Inc (LABT) to jump 78,052% by 2045, soaring from $480.55 to an average price of $480.40, potentially reaching $788.00. While $480.55 is the low estimate, the potential upside is significant.
- Lakewood Amedex Biotherapeutics Inc (LABT) stock is expected to climb by 2050, reaching an average of $1,504.00, a $244.57K% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,897.97 and $1,504.91, respectively, highlighting the market's uncertainty.
Lakewood Amedex Biotherapeutics Inc Stock (LABT) Year by Year Forecast
Lakewood Amedex Biotherapeutics Inc Stock (LABT) Price Forecast for 2026
The predicted value for Lakewood Amedex Biotherapeutics Inc (LABT) in 2026 is set at an average of $49.41. Estimates vary from a peak of $98.20 to a trough of $0.621, indicating an +7,938% surge from the present price of $0.6147.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $51.67 | $36.70 | $51.02 | +8,306% |
| December, 2026 | $45.28 | $45.53 | $48.26 | +7,266% |
Lakewood Amedex Biotherapeutics Inc Stock (LABT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lakewood Amedex Biotherapeutics Inc (LABT) is $80.24, with a high forecast of $158.06 and a low forecast of $2.4133. This indicates an +12,953% increase from the last price of $0.6147.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $37.27 | $37.50 | $42.79 | +5,962% |
| February, 2027 | $27.25 | $27.45 | $31.51 | +4,334% |
| March, 2027 | $15.26 | $15.59 | $24.77 | +2,383% |
| April, 2027 | $6.9179 | $6.9405 | $12.79 | +1,025% |
| May, 2027 | $101.80 | $2.4133 | $90.01 | +16,462% |
| June, 2027 | $110.09 | $103.59 | $109.44 | +17,810% |
| July, 2027 | $94.07 | $94.32 | $104.28 | +15,203% |
| August, 2027 | $70.85 | $71.76 | $89.17 | +11,427% |
| September, 2027 | $51.99 | $52.19 | $65.85 | +8,358% |
| October, 2027 | $32.75 | $33.08 | $46.79 | +5,227% |
| November, 2027 | $10.10 | $10.12 | $27.87 | +1,544% |
| December, 2027 | $169.86 | $5.4477 | $158.06 | +27,532% |
Lakewood Amedex Biotherapeutics Inc Stock (LABT) Price Forecast for 2028
In 2028, Lakewood Amedex Biotherapeutics Inc (LABT) is projected to reach an average price of $118.55, with a high projection of $228.61 and a low estimate of $8.482. This indicates an +19,185% rise from the last price of $0.6147.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $161.36 | $162.14 | $167.86 | +26,149% |
| February, 2028 | $136.00 | $136.18 | $153.00 | +22,024% |
| March, 2028 | $107.60 | $108.51 | $128.41 | +17,405% |
| April, 2028 | $79.11 | $79.30 | $100.19 | +12,769% |
| May, 2028 | $43.23 | $43.38 | $71.50 | +6,933% |
| June, 2028 | $15.55 | $15.57 | $35.90 | +2,429% |
| July, 2028 | $231.58 | $8.482 | $228.58 | +37,573% |
| August, 2028 | $217.37 | $218.15 | $228.61 | +35,262% |
| September, 2028 | $182.38 | $182.56 | $206.61 | +29,569% |
| October, 2028 | $135.34 | $135.56 | $172.39 | +21,917% |
| November, 2028 | $96.53 | $96.73 | $125.23 | +15,603% |
| December, 2028 | $58.31 | $58.46 | $86.62 | +9,386% |
Lakewood Amedex Biotherapeutics Inc Stock (LABT) Price Forecast for 2029
The 2029 price forecast for Lakewood Amedex Biotherapeutics Inc Stock (LABT) is $186.87 on average, with a high prediction of $362.21 and a low estimate of $11.52. This represents an +30,299% increase from the previous price of $0.6147.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $11.51 | $11.52 | $48.57 | +1,772% |
| February, 2029 | $297.22 | $300.52 | $294.22 | +48,252% |
| March, 2029 | $273.38 | $274.16 | $289.44 | +44,374% |
| April, 2029 | $217.11 | $217.25 | $260.21 | +35,219% |
| May, 2029 | $169.68 | $169.90 | $204.72 | +27,503% |
| June, 2029 | $121.23 | $121.43 | $157.16 | +19,623% |
| July, 2029 | $61.66 | $61.70 | $108.91 | +9,931% |
| August, 2029 | $14.54 | $14.55 | $49.16 | +2,265% |
| September, 2029 | $362.86 | $366.16 | $362.21 | +58,931% |
| October, 2029 | $313.95 | $315.51 | $350.27 | +50,973% |
| November, 2029 | $261.08 | $261.22 | $299.47 | +42,373% |
| December, 2029 | $189.37 | $189.64 | $246.28 | +30,706% |
Lakewood Amedex Biotherapeutics Inc Stock (LABT) Price Forecast for 2030
Lakewood Amedex Biotherapeutics Inc Stock (LABT) is expected to reach an average price of $260.35 in 2030, with a high forecast of $503.12 and a low forecast of $17.59. This signifies an +42,254% surge from the last price of $0.6147.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $131.29 | $131.57 | $174.68 | +21,259% |
| February, 2030 | $74.33 | $74.37 | $116.48 | +11,992% |
| March, 2030 | $17.57 | $17.59 | $59.42 | +2,759% |
| April, 2030 | $427.65 | $428.55 | $432.66 | +69,471% |
| May, 2030 | $367.55 | $369.12 | $411.10 | +59,694% |
| June, 2030 | $305.05 | $305.19 | $350.67 | +49,526% |
| July, 2030 | $221.30 | $221.57 | $287.84 | +35,901% |
| August, 2030 | $153.59 | $153.87 | $204.20 | +24,887% |
| September, 2030 | $70.85 | $70.89 | $136.38 | +11,427% |
| October, 2030 | $509.45 | $20.62 | $484.75 | +82,777% |
| November, 2030 | $490.89 | $491.79 | $503.12 | +79,758% |
| December, 2030 | $405.70 | $405.91 | $471.92 | +65,900% |
1.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):